Rankings
▼
Calendar
SEER
Seer, Inc.
$101M
FY 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$15M
+129.7% YoY
Gross Profit
$384,000
2.6% margin
Operating Income
-$98M
-667.6% margin
Net Income
-$93M
-633.1% margin
EPS (Diluted)
$-1.42
Cash Flow
Operating Cash Flow
-$61M
Free Cash Flow
-$71M
Stock-Based Comp.
$34M
Balance Sheet
Total Assets
$488M
Total Liabilities
$41M
Stockholders' Equity
$447M
Cash & Equivalents
$53M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$15M
$6M
+129.7%
Gross Profit
$384,000
-$374,000
+202.7%
Operating Income
-$98M
-$72M
-36.7%
Net Income
-$93M
-$71M
-30.6%
← Q4 2021
All Quarters
Q1 2022 →
SEER FY 2022 Earnings — Seer, Inc. Revenue & Financial Results | Market Cap Arena